Johnson & Johnson's orthopedics business reported $2.3 billion sales in the fourth quarter of 2016 and $9.3 billion for the full year.
Spinal Tech
Aliso Viejo, Calif.-based OrthAlign looks to promote the increasingly-popular transition from posterior to direct anterior approach in hip surgeries.
The FDA cleared Raynham, Mass.-based DePuy Synthes for its VIPER and EXPEDIUM Fenestrated Screw Systems.
Dallas-based Gramercy Extremity Orthopedics earned FDA clearance for its GEO Bone Screw System.
InVivo Therapeutics of Cambridge, Mass., has announced the improving condition of a spinal cord injury-affected patient enrolled in the INSPIRE study of the Neuro Spinal Scaffold.
Advertisement
Implanet has been granted permission by U.S. FDA and European CE to produce, promote, and sell the Jazz Frame, which will improve the quality of hybrid surgical techniques.
Carlsbad, Calif.-based Aurora Spine named Sarina Mason the new CFO.
Integra Derma began a cash tender offer to acquire Princeton, N.J.-based Derma Sciences. Integra Derma is a wholly-owned subsidiary of Plainsboro, N.J.-based Integra LifeSciences.
Johnson & Johnson's CEO Alex Gorsky will make responsible drug pricing a priority in the coming year after meeting with President Donald Trump, according to a Yahoo Finance report.
Pacira Pharmaceuticals partnered with DePuy Synthes Sales to market the company's bupivacaine liposome injectable suspension Exparel for orthopedic surgeries in the United States.